Inogen operates as an independent, publicly traded medical technology company listed on the NASDAQ exchange under the ticker symbol INGN, rather than being acquired by a larger healthcare conglomerate. The corporate entity retains its standalone operational autonomy while executing strategic international joint ventures and global distribution agreements.